Similar articles for PMID: 26833514

Year	Number of Results
1999	1
2001	1
2002	1
2006	1
2008	2
2009	2
2010	5
2011	2
2012	1
2013	3
2014	3
2015	11
2016	10
2017	16
2018	5
2019	8
2020	2
2024	0

1

Hypertension - state of the art 2015.

Floyd CN. Floyd CN. Clin Med (Lond). 2016 Feb;16(1):52-4. doi: 10.7861/clinmedicine.16-1-52. Clin Med (Lond). 2016. PMID: 26833514 Free PMC article.

2

The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update.

Nielsen PM, Grimm D, Wehland M, Simonsen U, Krüger M. Nielsen PM, et al. Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):9-18. doi: 10.1111/bcpt.12912. Epub 2017 Oct 11. Basic Clin Pharmacol Toxicol. 2018. PMID: 28944989 Free article. Review.

3

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

Ruilope LM, Dukat A, Böhm M, Lacourcière Y, Gong J, Lefkowitz MP. Ruilope LM, et al. Lancet. 2010 Apr 10;375(9722):1255-66. doi: 10.1016/S0140-6736(09)61966-8. Epub 2010 Mar 16. Lancet. 2010. PMID: 20236700 Clinical Trial.

4

AHU377+Valsartan (LCZ696) Modulates Renin-Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan.

Zhao Y, Ma R, Yu X, Li N, Zhao X, Yu J. Zhao Y, et al. J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):450-459. doi: 10.1177/1074248419838503. Epub 2019 Apr 25. J Cardiovasc Pharmacol Ther. 2019. PMID: 31023080

5

Blood-pressure reduction with LCZ696.

Waeber B, Feihl F. Waeber B, et al. Lancet. 2010 Apr 10;375(9722):1228-9. doi: 10.1016/S0140-6736(10)60363-7. Epub 2010 Mar 16. Lancet. 2010. PMID: 20236699 No abstract available.

6

Angiotensin II Receptor-Neprilysin Inhibitor Sacubitril/Valsartan Improves Endothelial Dysfunction in Spontaneously Hypertensive Rats.

Seki T, Goto K, Kansui Y, Ohtsubo T, Matsumura K, Kitazono T. Seki T, et al. J Am Heart Assoc. 2017 Oct 17;6(10):e006617. doi: 10.1161/JAHA.117.006617. J Am Heart Assoc. 2017. PMID: 29042424 Free PMC article.

7

LCZ696 (Valsartan/Sacubitril)--A Possible New Treatment for Hypertension and Heart Failure.

Andersen MB, Simonsen U, Wehland M, Pietsch J, Grimm D. Andersen MB, et al. Basic Clin Pharmacol Toxicol. 2016 Jan;118(1):14-22. doi: 10.1111/bcpt.12453. Epub 2015 Sep 4. Basic Clin Pharmacol Toxicol. 2016. PMID: 26280447 Free article. Review.

8

Effects of Sacubitril/Valsartan (LCZ696) on Natriuresis, Diuresis, Blood Pressures, and NT-proBNP in Salt-Sensitive Hypertension.

Wang TD, Tan RS, Lee HY, Ihm SH, Rhee MY, Tomlinson B, Pal P, Yang F, Hirschhorn E, Prescott MF, Hinder M, Langenickel TH. Wang TD, et al. Hypertension. 2017 Jan;69(1):32-41. doi: 10.1161/HYPERTENSIONAHA.116.08484. Epub 2016 Nov 14. Hypertension. 2017. PMID: 27849566 Clinical Trial.

9

Efficacy and Safety of Crystalline Valsartan/Sacubitril (LCZ696) Compared With Placebo and Combinations of Free Valsartan and Sacubitril in Patients With Systolic Hypertension: The RATIO Study.

Izzo JL Jr, Zappe DH, Jia Y, Hafeez K, Zhang J. Izzo JL Jr, et al. J Cardiovasc Pharmacol. 2017 Jun;69(6):374-381. doi: 10.1097/FJC.0000000000000485. J Cardiovasc Pharmacol. 2017. PMID: 28338503 Clinical Trial.

10

Antihypertensive Efficacy of LCZ696 (Sacubitril/Valsartan) in Hypertension.

Tocci G. Tocci G. Cardiology. 2020;145(9):599-600. doi: 10.1159/000508345. Epub 2020 Jul 2. Cardiology. 2020. PMID: 32615561 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year